801 E. Morehead Street
15 articles with SonaCare Medical
SonaCare Medical's CSO, Naren Sanghvi, Recognized by Prestigious Focused Ultrasound Foundation with 2018 Visionary Award
SonaCare Medical congratulates Naren Sanghvi on his receipt of the Focused Ultrasound Foundation's 2018 Visionary Award, which recognizes his crucial role in advancing the field of focused ultrasound.
SonaCare Medical Gathers Global Thought Leaders of Focal Therapy for Prostate Cancer at 3rd Annual Sonablate® User Group Meeting
SonaCare Medical hosted over 75 attendees at this year's Sonablate® User Group Meeting, which makes this meeting the most prolific gathering of urologic focal therapy specialists ever in the state of North Carolina.
5-Year Outcomes Following A HIFU Focal Therapy Study Demonstrate Impressive Disease Control And Low Side Effect Profile For Prostate Cancer Patients In The U.K.
SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, is pleased to report 5-year outcomes from a multicenter study following focal therapy treatment with its Sonablate technology of 625 medium to high-risk clinically significant nonmetastatic prostate cancer patients.
Over 120 urologists gather at Imperial College London to learn new diagnostic techniques and minimally invasive focal approaches for treating prostate cancer.
The Journal Of Therapeutic Ultrasound Publishes Article On SonaCare Medical's Sonablate HIFU Technology
SonaCare Medical Paves The Way With The First HIFU Device Cleared By The FDA For Prostate Tissue Ablation - A Year In Review
SonaCare Medical And Invivo Corporation Join Forces To Help Physicians Better Locate And Track Appropriate Targets For Prostate HIFU Ablation
FDA Approves SonaCare Medical's Sonablate High Intensity Focused Ultrasound Prostate Ablation Device
SonaCare Medical Reports Continued Growth In Sales Of High Intensity Focused Ultrasound Ablation Devices In Europe